{"id":7510,"date":"2021-10-07T20:25:05","date_gmt":"2021-10-08T03:25:05","guid":{"rendered":"https:\/\/peninsula360press.com\/?p=7510"},"modified":"2021-10-07T20:25:10","modified_gmt":"2021-10-08T03:25:10","slug":"pfizer-and-biotech-request-emergency-use-of-covid-19-vaccine-for-children-aged-5-to-11","status":"publish","type":"post","link":"https:\/\/peninsula360press.com\/en\/pfizer-and-biotech-request-emergency-use-of-covid-19-vaccine-for-children-aged-5-to-11\/","title":{"rendered":"Pfizer and BioNTech Request Emergency Use of COVID-19 Vaccine for Children 5 to 11 Years of Age"},"content":{"rendered":"
\"Vaccine<\/figure>\n\n\n\n

After cases of COVID-19 in children in the U.S. continue to rise, Pfizer and BioNTech<\/a> applied to the U.S. Food and Drug Administration (FDA) for emergency approval of their vaccine for use in children 5 to 11 years of age. (FDA) for emergency use authorization of their vaccine in children 5 to 11 years of age.<\/p>\n\n\n\n

Both the pharmaceutical and the biotech company said the application \"is an important step in our ongoing effort against COVID-19.<\/p>\n\n\n\n

They noted that, according to the American Academy of Pediatrics and the Children's Hospital Association, from Sept. 16 to Sept. 30 of this year, there was a 7.0 percent increase in the cumulative number of cases of children with COVID-19 since the pandemic began.  <\/p>\n\n\n\n

In this regard, he noted that to date, children account for 16 percent of the total cumulative cases of COVID-19. Meanwhile, during the last week of September, children - under 18 years of age - accounted for 27 percent of all weekly COVID-19 cases in the country.<\/p>\n\n\n\n

\"We are committed to working with the FDA to help protect children from this serious public health threat,\" Pfizer said on social media.<\/p>\n\n\n\n

So far, the FDA has only licensed the Pfizer\/BioNTech vaccine -Comirnaty- for use in people 12 years and older, with one 30-microgram dose injected in the arm and a sequence of two more 21 days apart.<\/p>\n\n\n\n

Just last September 28, the companies announced positive top-line results from the trial involving 2,268 participants aged 5 to 11 years, in which the vaccine demonstrated a favorable safety profile and elicited robust neutralizing antibody responses using two doses of 10 micrograms each.<\/p>\n\n\n\n

These results, the first from a pivotal trial of any COVID-19 vaccine in this age group, were comparable to those recorded in an earlier Pfizer-BioNTech study in 16- to 25-year-olds, who were immunized with 30 \u03bcg doses. The 10 \u03bcg dose was carefully selected as the preferred dose for safety, tolerability and immunogenicity in children aged 5 to 11 years.<\/p>\n\n\n\n

Pfizer-BioNTech COVID-19 vaccine based on mRNA technology <\/p>\n\n\n\n

Meanwhile, White House COVID-19 response coordinator Jeff Zients told CNN that the vaccine for children could be ready before Thanksgiving, following Pfizer's request for emergency use authorization this morning.<\/p>\n\n\n\n

The announcement comes just days before Halloween is celebrated in the country, when millions of children take to the streets in search of candy, a date that last year was diminished by the pandemic that was showing its worst face at that time.<\/p>\n\n\n\n

In turn, it comes to reassure the requests of millions of parents who have shown their concern and need for their children to be vaccinated after classes have begun across the country.\u00a0<\/p>\n\n\n\n

You may be interested in: Third Dose of COVID-19 Vaccine Divides Opinion Among Scientific Community<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"

Luego de que los casos de COVID-19 en ni\u00f1os en EE. UU. contin\u00faan creciendo, Pfizer y BioNTech solicitaron a la Administraci\u00f3n de Alimentos y Medicamentos de EE. UU. (FDA, por sus siglas en ingl\u00e9s), la autorizaci\u00f3n de uso de emergencia de su vacuna en\u00a0ni\u00f1os de 5 a 11 a\u00f1os. Tanto la farmac\u00e9utica como la empresa […]<\/p>","protected":false},"author":7,"featured_media":6891,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,170,12],"tags":[],"class_list":{"0":"post-7510","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-cover","8":"category-covid19","9":"category-health"},"_links":{"self":[{"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/posts\/7510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/comments?post=7510"}],"version-history":[{"count":1,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/posts\/7510\/revisions"}],"predecessor-version":[{"id":7511,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/posts\/7510\/revisions\/7511"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/media\/6891"}],"wp:attachment":[{"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/media?parent=7510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/categories?post=7510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/peninsula360press.com\/en\/wp-json\/wp\/v2\/tags?post=7510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}